KWKang Wu

Kang Wu

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kang Wu has a total of 25 co-authors. Here are the top co-authors by number of shared publications:

  • Bingjiao Zhao

    Department of Orthodontics, Shanghai Stomatological Hospital & School of Stomatology, Fudan University, Shanghai, China

    1 shared publication
  • Chuangchuang Mu

    Department of Macromolecular Science, Department of Orthodontics, Multidisciplinary Consultant Center, Shanghai Stomatological Hospital & School of Stomatology, Fudan University, Shanghai, 200433, China

    1 shared publication
  • Dan Zhang

    School of Ophthalmology & Optometry, Eye Hospital, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang 325027, China

    1 shared publication
  • Fengcheng Chu

    Orthopedic Institute, Department of Orthopedics, The First Affiliated Hospital, Soochow University, Suzhou, China

    1 shared publication
  • Hua Yang

    Hebei university of Technology

    1 shared publication
  • Huajian Gao

    Mechano-X Institute, Applied Mechanics Laboratory, Department of Engineering Mechanics, Tsinghua University, Beijing, China

    1 shared publication

Latest Publications

  • Open Access

    A sequential drug delivery system based on silk fibroin scaffold for effective cartilage repair

    by Menglin Xiao, Liangyan Sun, Kang Wu, Yuqi Ding, Peipei Wang, Chuangchuang Mu, Jinrong Yao, Zhengzhong Shao, Bingjiao Zhao, Xin Chen

    Endogenous repair of cartilage defects is a preferential strategy for cartilage repair, but always hindered by insufficient early-stage cells and incomplete cell differentiation at later stages. For in-situ cartilage regeneration, it is crucial to develop a sequential drug release system capable of recruiting endogenous bone marrow mesenchymal stem cells (BMSCs) and promoting their chondrogenic differentiation. Herein, based on our long-term and fruitful research on silk fibroin (SF) porous scaffolds, a cell-free sequential drug delivery SF scaffold was developed. BMSCs affinity peptide PFSSTKT (PFS) was coated on the surface of SF scaffold, in which chondrogenic inducer kartogenin (KGN) and anti-inflammatory factor dexamethasone (DEX) were loaded. PFS was rapidly released within the first 10 days while KGN and DEX could be released over 28 days. The scaffold promoted BMSCs migration and chondrogenic differentiation through the release of PFS and KGN in vitro. Finally, the sequential drug released by the implanted SF scaffolds in rats indeed recruited endogenous BMSCs and significantly promoted the in-situ regeneration of their knee cartilage defects. In summary, this study not only introduces a green and environmentally friendly all silk-based sequential drug delivery system, but also provides an effective tissue engineering functional scaffold for in-situ cartilage regeneration.


  • Open Access

    Mechanobiomaterials: Harnessing mechanobiology principles for tissue repair and regeneration

    by Xiao Lin, Hua Yang, Yi Xia, Kang Wu, Fengcheng Chu, Huan Zhou, Huajian Gao, Lei Yang


  • Open Access

    A TGF-loading hydrogel scaffold capable of promoting chondrogenic differentiation for repairing rabbit nasal septum cartilage defect

    by Dan Zhang, Ying Su, Peng Sun, Xingzhi Liu, Lin Zhang, Xuwei Ling, Yuhui Fan, Kang Wu, Qin Shi, Jisheng Liu

    Hydrogel-based tissue engineering has been widely used to repair cartilage injury. However, whether this approach can be applied to treat nasal septum cartilage defects remains unclear. In this study, three gelatin methacrylate-based scaffolds loaded with transforming growth factor (TGF)-β1 (GelMA-T) were prepared, and their effects on repair of nasal septum cartilage defects were examined. In vitro, the GelMA-T scaffolds showed good biocompatibility and promoted the chondrogenic differentiation of bone mesenchymal stem cells. Among three scaffolds, the 10% GelMA-T scaffold promoted chondrogenic differentiation most effectively, which significantly improved the expression of chondrocyte-related genes, including Col II, Sox9, and ACAN. In vivo, 10% GelMA-T scaffolds and 10% GelMA-T scaffolds loaded with bone mesenchymal stem cells (BMSCs; 10% GelMA-T/BMSCs) were transplanted into a nasal septum cartilage defect site in a rabbit model. At 4, 12, and 24 weeks after surgery, the nasal septum cartilage defects exhibited more complete repair in rabbits treated with the 10% GelMA-T/BMSC scaffold as demonstrated by hematoxylin & eosin, safranine-O, and toluidine blue staining. We showed that GelMA-T/BMSCs can be applied in physiological and structural repair of defects in nasal septum cartilage, providing a potential strategy for repairing cartilage defects in the clinic.